Spatial Transcriptomics Market Size to Hit USD 1,569.03 Million by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Spatial Transcriptomics Market

5.1. COVID-19 Landscape: Spatial Transcriptomics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Spatial Transcriptomics Market, By Technology

8.1. Spatial Transcriptomics Market Revenue and Volume, by Technology

8.1.1. Imaging-Based Spatial Transcriptomics

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Sequencing-Based Spatial Transcriptomics

8.1.2.1. Market Revenue and Volume Forecast

Chapter 9. Global Spatial Transcriptomics Market, By Product & Solution

9.1. Spatial Transcriptomics Market Revenue and Volume, by Product & Solution

9.1.1. Instruments

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Consumables

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Software & Services

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Spatial Transcriptomics Market, By Sample Type

10.1. Spatial Transcriptomics Market Revenue and Volume, by Sample Type

10.1.1. FFPE (Formalin-Fixed Paraffin-Embedded) Tissues

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Fresh Frozen Tissues

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Organoids & Cell Cultures

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Others (e.g., Biopsy Punches, Cryosections)

10.1.4.1. Market Revenue and Volume Forecast

Chapter 11. Global Spatial Transcriptomics Market, By Workflow Stage

11.1. Spatial Transcriptomics Market Revenue and Volume, by Workflow Stage

11.1.1. Sample Preparation

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Spatial Barcoding

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Imaging/Sequencing

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Data Analysis & Interpretation

11.1.4.1. Market Revenue and Volume Forecast

Chapter 12. Global Spatial Transcriptomics Market, By Application

12.1. Spatial Transcriptomics Market Revenue and Volume, by Application

12.1.1. Oncology

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Neuroscience

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Developmental Biology

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Immunology

12.1.4.1. Market Revenue and Volume Forecast

12.1.5. Drug Discovery & Toxicology

12.1.5.1. Market Revenue and Volume Forecast

12.1.6. Others (e.g., Cardiovascular Research, Infectious Diseases)

12.1.6.1. Market Revenue and Volume Forecast

Chapter 13. Global Spatial Transcriptomics Market, By End User

13.1. Spatial Transcriptomics Market Revenue and Volume, by End User

13.1.1. Academic & Research Institutes

13.1.1.1. Market Revenue and Volume Forecast

13.1.2. Pharmaceutical & Biotechnology Companies

13.1.2.1. Market Revenue and Volume Forecast

13.1.3. Contract Research Organizations (CROs)

13.1.3.1. Market Revenue and Volume Forecast

13.1.4. Hospitals & Diagnostic Centers

13.1.4.1. Market Revenue and Volume Forecast

13.1.5. Others (e.g., Government Labs, Pathology Labs)

13.1.5.1. Market Revenue and Volume Forecast

Chapter 14. Global Spatial Transcriptomics Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Volume Forecast, by Technology

14.1.2. Market Revenue and Volume Forecast, by Product & Solution

14.1.3. Market Revenue and Volume Forecast, by Sample Type

14.1.4. Market Revenue and Volume Forecast, by Workflow Stage

14.1.5. Market Revenue and Volume Forecast, by Application

14.1.6. Market Revenue and Volume Forecast, by End User

14.1.7. U.S.

14.1.7.1. Market Revenue and Volume Forecast, by Technology

14.1.7.2. Market Revenue and Volume Forecast, by Product & Solution

14.1.7.3. Market Revenue and Volume Forecast, by Sample Type

14.1.7.4. Market Revenue and Volume Forecast, by Workflow Stage

14.1.8. Market Revenue and Volume Forecast, by Application

14.1.8.1. Market Revenue and Volume Forecast, by End User

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Volume Forecast, by Technology

14.1.9.2. Market Revenue and Volume Forecast, by Product & Solution

14.1.9.3. Market Revenue and Volume Forecast, by Sample Type

14.1.9.4. Market Revenue and Volume Forecast, by Workflow Stage

14.1.10. Market Revenue and Volume Forecast, by Application

14.1.11. Market Revenue and Volume Forecast, by End User

14.2. Europe

14.2.1. Market Revenue and Volume Forecast, by Technology

14.2.2. Market Revenue and Volume Forecast, by Product & Solution

14.2.3. Market Revenue and Volume Forecast, by Sample Type

14.2.4. Market Revenue and Volume Forecast, by Workflow Stage

14.2.5. Market Revenue and Volume Forecast, by Application

14.2.6. Market Revenue and Volume Forecast, by End User

14.2.8. UK

14.2.8.1. Market Revenue and Volume Forecast, by Technology

14.2.8.2. Market Revenue and Volume Forecast, by Product & Solution

14.2.8.3. Market Revenue and Volume Forecast, by Sample Type

14.2.9. Market Revenue and Volume Forecast, by Workflow Stage

14.2.10. Market Revenue and Volume Forecast, by Application

14.2.10.1. Market Revenue and Volume Forecast, by End User

14.2.11. Germany

14.2.11.1. Market Revenue and Volume Forecast, by Technology

14.2.11.2. Market Revenue and Volume Forecast, by Product & Solution

14.2.11.3. Market Revenue and Volume Forecast, by Sample Type

14.2.12. Market Revenue and Volume Forecast, by Workflow Stage

14.2.13. Market Revenue and Volume Forecast, by Application

14.2.14. Market Revenue and Volume Forecast, by End User

14.2.15. France

14.2.15.1. Market Revenue and Volume Forecast, by Technology

14.2.15.2. Market Revenue and Volume Forecast, by Product & Solution

14.2.15.3. Market Revenue and Volume Forecast, by Sample Type

14.2.15.4. Market Revenue and Volume Forecast, by Workflow Stage

14.2.16. Market Revenue and Volume Forecast, by Application

14.2.16.1. Market Revenue and Volume Forecast, by End User

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Volume Forecast, by Technology

14.2.17.2. Market Revenue and Volume Forecast, by Product & Solution

14.2.17.3. Market Revenue and Volume Forecast, by Sample Type

14.2.17.4. Market Revenue and Volume Forecast, by Workflow Stage

14.2.18. Market Revenue and Volume Forecast, by Application

14.2.18.1. Market Revenue and Volume Forecast, by End User

14.3. APAC

14.3.1. Market Revenue and Volume Forecast, by Technology

14.3.2. Market Revenue and Volume Forecast, by Product & Solution

14.3.3. Market Revenue and Volume Forecast, by Sample Type

14.3.4. Market Revenue and Volume Forecast, by Workflow Stage

14.3.5. Market Revenue and Volume Forecast, by Application

14.3.6. Market Revenue and Volume Forecast, by End User

14.3.7. India

14.3.7.1. Market Revenue and Volume Forecast, by Technology

14.3.7.2. Market Revenue and Volume Forecast, by Product & Solution

14.3.7.3. Market Revenue and Volume Forecast, by Sample Type

14.3.7.4. Market Revenue and Volume Forecast, by Workflow Stage

14.3.8. Market Revenue and Volume Forecast, by Application

14.3.9. Market Revenue and Volume Forecast, by End User

14.3.10. China

14.3.10.1. Market Revenue and Volume Forecast, by Technology

14.3.10.2. Market Revenue and Volume Forecast, by Product & Solution

14.3.10.3. Market Revenue and Volume Forecast, by Sample Type

14.3.10.4. Market Revenue and Volume Forecast, by Workflow Stage

14.3.11. Market Revenue and Volume Forecast, by Application

14.3.11.1. Market Revenue and Volume Forecast, by End User

14.3.12. Japan

14.3.12.1. Market Revenue and Volume Forecast, by Technology

14.3.12.2. Market Revenue and Volume Forecast, by Product & Solution

14.3.12.3. Market Revenue and Volume Forecast, by Sample Type

14.3.12.4. Market Revenue and Volume Forecast, by Workflow Stage

14.3.12.5. Market Revenue and Volume Forecast, by Application

14.3.12.6. Market Revenue and Volume Forecast, by End User

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Volume Forecast, by Technology

14.3.13.2. Market Revenue and Volume Forecast, by Product & Solution

14.3.13.3. Market Revenue and Volume Forecast, by Sample Type

14.3.13.4. Market Revenue and Volume Forecast, by Workflow Stage

14.3.13.5. Market Revenue and Volume Forecast, by Application

14.3.13.6. Market Revenue and Volume Forecast, by End User

14.4. MEA

14.4.1. Market Revenue and Volume Forecast, by Technology

14.4.2. Market Revenue and Volume Forecast, by Product & Solution

14.4.3. Market Revenue and Volume Forecast, by Sample Type

14.4.4. Market Revenue and Volume Forecast, by Workflow Stage

14.4.5. Market Revenue and Volume Forecast, by Application

14.4.6. Market Revenue and Volume Forecast, by End User

14.4.7. GCC

14.4.7.1. Market Revenue and Volume Forecast, by Technology

14.4.7.2. Market Revenue and Volume Forecast, by Product & Solution

14.4.7.3. Market Revenue and Volume Forecast, by Sample Type

14.4.7.4. Market Revenue and Volume Forecast, by Workflow Stage

14.4.8. Market Revenue and Volume Forecast, by Application

14.4.9. Market Revenue and Volume Forecast, by End User

14.4.10. North Africa

14.4.10.1. Market Revenue and Volume Forecast, by Technology

14.4.10.2. Market Revenue and Volume Forecast, by Product & Solution

14.4.10.3. Market Revenue and Volume Forecast, by Sample Type

14.4.10.4. Market Revenue and Volume Forecast, by Workflow Stage

14.4.11. Market Revenue and Volume Forecast, by Application

14.4.12. Market Revenue and Volume Forecast, by End User

14.4.13. South Africa

14.4.13.1. Market Revenue and Volume Forecast, by Technology

14.4.13.2. Market Revenue and Volume Forecast, by Product & Solution

14.4.13.3. Market Revenue and Volume Forecast, by Sample Type

14.4.13.4. Market Revenue and Volume Forecast, by Workflow Stage

14.4.13.5. Market Revenue and Volume Forecast, by Application

14.4.13.6. Market Revenue and Volume Forecast, by End User

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Volume Forecast, by Technology

14.4.14.2. Market Revenue and Volume Forecast, by Product & Solution

14.4.14.3. Market Revenue and Volume Forecast, by Sample Type

14.4.14.4. Market Revenue and Volume Forecast, by Workflow Stage

14.4.14.5. Market Revenue and Volume Forecast, by Application

14.4.14.6. Market Revenue and Volume Forecast, by End User

14.5. Latin America

14.5.1. Market Revenue and Volume Forecast, by Technology

14.5.2. Market Revenue and Volume Forecast, by Product & Solution

14.5.3. Market Revenue and Volume Forecast, by Sample Type

14.5.4. Market Revenue and Volume Forecast, by Workflow Stage

14.5.5. Market Revenue and Volume Forecast, by Application

14.5.6. Market Revenue and Volume Forecast, by End User

14.5.7. Brazil

14.5.7.1. Market Revenue and Volume Forecast, by Technology

14.5.7.2. Market Revenue and Volume Forecast, by Product & Solution

14.5.7.3. Market Revenue and Volume Forecast, by Sample Type

14.5.7.4. Market Revenue and Volume Forecast, by Workflow Stage

14.5.8. Market Revenue and Volume Forecast, by Application

14.5.8.1. Market Revenue and Volume Forecast, by End User

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Volume Forecast, by Technology

14.5.9.2. Market Revenue and Volume Forecast, by Product & Solution

14.5.9.3. Market Revenue and Volume Forecast, by Sample Type

14.5.9.4. Market Revenue and Volume Forecast, by Workflow Stage

14.5.9.5. Market Revenue and Volume Forecast, by Application

14.5.9.6. Market Revenue and Volume Forecast, by End User

Chapter 15. Company Profiles

15.1. Akoya Biosciences, Inc.

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Vizgen, Inc.

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Dovetail Genomics

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Resolve Biosciences

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Molecular Cartography

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Veranome Biosystems

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Ultivue, Inc.

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. OriGene Technologies, Inc.

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. NanoString Technologies, Inc.

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. 10x Genomics, Inc.

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The spatial transcriptomics market size is expected to increase from USD 410.46 million in 2024 to USD 1,569.03 million by 2034.

The spatial transcriptomics market is expected to grow at a compound annual growth rate (CAGR) of around 14.35% from 2025 to 2034.

The major players in the spatial transcriptomics market include 10x Genomics, Inc., NanoString Technologies, Inc., Akoya Biosciences, Inc., Vizgen, Inc., Bruker Corporation, Bio-Techne Corporation, Illumina, Fluidigm Corporation, ReadCoor, Inc, CARTANA AB, Dovetail Genomics, Resolve Biosciences, Molecular Cartography, Spatial Genomics, Inc.,Pixelgen Technologies AB, Veranome Biosystems, ACD Bio (Advanced Cell Diagnostics), NuProbe Inc., OriGene Technologies, Inc.,and Ultivue, Inc.

The driving factors of the spatial transcriptomics market are the ongoing advancements in technologies, including enhanced imaging, higher throughput capabilities, and improved resolution, are driving market growth.

North America region will lead the global spatial transcriptomics market during the forecast period 2025 to 2034.